Foghorn Therapeutics Inc (FHTX)
8.72
+0.48
(+5.83%)
USD |
NASDAQ |
Nov 05, 14:35
Foghorn Therapeutics Total Assets (Quarterly): 328.58M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 328.58M |
| March 31, 2024 | 255.00M |
| December 31, 2023 | 285.92M |
| September 30, 2023 | 313.42M |
| June 30, 2023 | 339.58M |
| March 31, 2023 | 372.88M |
| December 31, 2022 | 404.88M |
| September 30, 2022 | 433.93M |
| June 30, 2022 | 456.90M |
| Date | Value |
|---|---|
| March 31, 2022 | 488.30M |
| December 31, 2021 | 519.77M |
| September 30, 2021 | 186.07M |
| June 30, 2021 | 208.53M |
| March 31, 2021 | 229.89M |
| December 31, 2020 | 255.59M |
| September 30, 2020 | 142.43M |
| June 30, 2020 | 94.31M |
| December 31, 2019 | 22.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.34M
Minimum
Dec 2019
519.77M
Maximum
Dec 2021
296.57M
Average
299.67M
Median
Total Assets (Quarterly) Benchmarks
| Sana Biotechnology Inc | 618.67M |
| Omega Therapeutics Inc | 168.22M |
| Moderna Inc | 15.68B |
| Corcept Therapeutics Inc | 784.26M |
| Akebia Therapeutics Inc | 220.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 342.91M |
| Shareholders Equity (Quarterly) | -14.32M |
| Current Ratio | 5.693 |